Based on this idea, the following sections present evidence that supports the importance of GSK3α in neurodegenerative disorders (ND) and brain cancer, pancreatic ductal adenocarcinoma, prostate cancer, acute myeloid leukemia, multiple myeloma, and lung cancer. The gene discussed is GSK3A; the disease is brain cancer.